NVAX vs. OCGN
NVAX (Novavax, Inc.) and OCGN (Ocugen, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, NVAX returned -23.71%/yr vs -2.50%/yr for OCGN. At a 0.25 correlation, their price movements are largely independent.
Performance
NVAX vs. OCGN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVAX achieves a 32.44% return, which is significantly higher than OCGN's 2.96% return. Over the past 10 years, NVAX has underperformed OCGN with an annualized return of -23.71%, while OCGN has yielded a comparatively higher -2.50% annualized return.
NVAX
- 1D
- -1.11%
- 1M
- -3.37%
- YTD
- 32.44%
- 6M
- 28.24%
- 1Y
- 37.13%
- 3Y*
- 9.93%
- 5Y*
- -45.77%
- 10Y*
- -23.71%
OCGN
- 1D
- 0.72%
- 1M
- 3.73%
- YTD
- 2.96%
- 6M
- -3.47%
- 1Y
- 34.30%
- 3Y*
- 37.93%
- 5Y*
- -30.13%
- 10Y*
- -2.50%
NVAX vs. OCGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVAX Novavax, Inc. | 32.44% | -16.42% | 67.50% | -53.31% | -92.81% | 28.30% | 2,701.76% | -89.18% | 48.39% | -1.59% |
OCGN Ocugen, Inc. | 2.96% | 67.70% | 40.00% | -55.77% | -71.43% | 148.63% | 251.92% | 488.24% | -95.69% | 22.75% |
Correlation
The correlation between NVAX and OCGN is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.41 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Dec 3, 2014 | 0.25 |
The correlation between NVAX and OCGN shifts across timeframes, from 0.25 (all time) to 0.41 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
NVAX:
$1.45B
OCGN:
$445.39M
NVAX:
-$0.52
OCGN:
-$0.23
NVAX:
2.52
OCGN:
95.63
NVAX:
$596.34M
OCGN:
$4.47M
NVAX:
$504.72M
OCGN:
$2.93M
NVAX:
-$57.01M
OCGN:
-$64.77M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVAX vs. OCGN — Risk / Return Rank
NVAX
OCGN
NVAX vs. OCGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novavax, Inc. (NVAX) and Ocugen, Inc. (OCGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVAX | OCGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.12 | ||
| Sortino ratioReturn per unit of downside risk | +0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.15 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 1.04 | 0.66 | +0.38 |
| Martin ratioReturn relative to average drawdown | 2.00 | 1.38 | +0.62 |
Loading charts...
Drawdowns
NVAX vs. OCGN - Drawdown Comparison
The maximum NVAX drawdown since its inception was -98.82%, roughly equal to the maximum OCGN drawdown of -99.25%. Use the drawdown chart below to compare losses from any high point for NVAX and OCGN.
Loading charts...
Drawdown Indicators
| NVAX | OCGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.82% | -99.25% | +0.43% |
Max Drawdown (1Y)Largest decline over 1 year | -35.94% | -52.42% | +16.48% |
Max Drawdown (3Y)Largest decline over 3 years | -74.11% | -73.92% | -0.19% |
Max Drawdown (5Y)Largest decline over 5 years | -98.61% | -97.71% | -0.90% |
Max Drawdown (10Y)Largest decline over 10 years | -98.82% | -97.80% | -1.02% |
Current DrawdownCurrent decline from peak | -97.22% | -91.21% | -6.01% |
Average DrawdownAverage peak-to-trough decline | -70.79% | -81.75% | +10.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.64% | 25.01% | -6.37% |
Volatility
NVAX vs. OCGN - Volatility Comparison
Novavax, Inc. (NVAX) has a higher volatility of 23.60% compared to Ocugen, Inc. (OCGN) at 15.39%. This indicates that NVAX's price experiences larger fluctuations and is considered to be riskier than OCGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVAX | OCGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.60% | 15.39% | +8.21% |
Volatility (6M)Calculated over the trailing 6-month period | 52.58% | 63.41% | -10.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.57% | 80.45% | -11.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.99% | 90.35% | +15.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 115.55% | 550.74% | -435.19% |
Dividends
NVAX vs. OCGN - Dividend Comparison
Neither NVAX nor OCGN has paid dividends to shareholders.
Financials
NVAX vs. OCGN - Financials Comparison
This section allows you to compare key financial metrics between Novavax, Inc. and Ocugen, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVAX and OCGN have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVAX has higher volatility (23.60%) compared to OCGN (15.39%). In terms of maximum drawdown, NVAX dropped -98.82% vs OCGN's -99.25%.
NVAX currently has the higher Sharpe Ratio (0.54 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVAX and OCGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer